CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for OCTAPHARMA USA, INC. · Pharmaceuticals

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · Senate · $90,000.00 income · posted Apr 15, 2026

Lobbying activity 3

Trade (domestic/foreign)

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Medical/Disease Research/Clinical Labs

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Manufacturing

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.